HLSHealiusHLS info
$0.86info0.91%24h
Global rank
Market cap$627.41M
Change 7d-
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Healius (HLS) Stock Overview

    Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

    HLS Stock Information

    Symbol
    HLS
    Address
    Liberty PlaceSydney, NSW 2000Australia
    Founded
    -
    Trading hours
    10:00 AM - 4:00 PM AEST
    Website
    https://www.healius.com.au
    Country
    🇦🇺 Australia
    Phone Number
    61 2 9432 9400

    Healius (HLS) Price Chart

    -
    Value:-

    Healius Overview: Key Details and Summary

    Stock data
    2025
    Change
    Price
    $0.864114492834856
    N/A
    Market Cap
    $627.41M
    N/A
    Shares Outstanding
    726.07M
    N/A
    Employees
    10.50K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2025 Topstocks.org